Assaying the Potency of Influenza Vaccines.

Vaccines (Basel)

National Institute for Biological Standards and Control/MHRA, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, UK.

Published: February 2015

The potency of vaccines must be determined to ensure that the appropriate dose is given. The manufacture and assessment of influenza vaccines are complicated by the continuously changing nature of the pathogen, which makes efficacy estimates difficult but also confounds attempts to produce a well-validated, consistent potency assay. Single radial diffusion has been used for decades and provides a relatively simple way to measure the amount of biologically active materials present in the vaccine. It requires reagents, which are updated on a regular, frequently yearly, basis and alternative methods continue to be sought.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494238PMC
http://dx.doi.org/10.3390/vaccines3010090DOI Listing

Publication Analysis

Top Keywords

influenza vaccines
8
assaying potency
4
potency influenza
4
vaccines potency
4
potency vaccines
4
vaccines determined
4
determined ensure
4
ensure appropriate
4
appropriate dose
4
dose manufacture
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!